GiveWell does complicated work to make charity-picking easy for everyday people by doing very
thorough vetting of charities and recommending a few top ones. Like IPA, they place a premium on data and being able to assess an organization’s effectiveness.
That’s why we’re thrilled at this year’s top choices, which are all close to IPA’s heart, or in this case, data. Two of the three organizations chosen have had close, data-driven relationships with us, and the third’s work is similarly grounded in many of our findings. We agree wholeheartedly with GiveWell’s recommendations:
GiveDirectly gives “unconditional cash transfers” (economist speak for “free money”) directly to poor people, allowing them to spend it as they wish. The organization was founded by a number of economics students because the idea had been thoroughly theorized about but not definitively studied. Part of the plan was to incubate the idea in the context of a study conducted through
IPA-Kenya, with researchers
Johannes Haushofer and
Jeremy Shapiro. The results, summarized
here, showed that the poor were able to use the money effectively to improve their economic situations and well-being, and didn’t spend it on alcohol and tobacco. GiveDirectly is now
expanding into Uganda as well.
You can hear IPA’s founder
Dean Karlan and behavioral economist
Richard Thaler, discussing the results in a recent Freakonomics Radio podcast
here.
The other two top charities recommended deal with a topic we’ve been heavily involved with, inexpensive “deworming” treatment for parasites, particularly in children.
Our work has shown that these treatments, which often cost far less than a dollar per child at scale, increase graduation rates. When we followed up ten years later, we found young adults who’d received the deworming pills as students were earning significantly more. The
Deworm the World Initiative took the expertise in administering deworming programs to scale, and after reaching tens of millions of children, we recently launched
Evidence Action as an independent organization to further expand it and other proven interventions.
The other charity, the Schistosomiasis Control Initiative (SCI), does similar work, helping African Governments scale up deworming programs. The fact that two of the three charities are based on the deworming research stresses its importance.
Soon after the GiveWell’s announcement
Good Ventures announced over
$4 million in grants to these organizations and up to an additional $5 million in matching funds for donations to GiveDirectly. More than just an end-of-year philanthropic donation, this represents the ideal cylcle for evidence-based philanthropy. An idea is proven through research to be effective, vetted by outside organizations, and with philanthropies, individuals, and aid organizations knowing exactly what they’re getting, they can donate with confidence.
We applaud these organizations' commitment to evidence-driven philanthropy and look forward to many more years of data-driven recommendations and action.